Control cells stimulated with S100A4 and PAH‐PASMCs had a 3‐fold decrease in PPARγ expression (percentage of cells with PPARγ activated of total cells measured by DAPI). The gene discussed is S100A4; the disease is pulmonary arterial hypertension.